Hello and good evening. I am writing to you as a long

New Post Public Reply Private Reply Replies (1) Message Board
avboy

Hello and good evening. I am writing to you as a long term investor in CEN-Biotech (ticker FITX), and in full support of the company. I would like to give some historical background and investor perspective. I would sincerely appreciate if you would spend the time to read it, and pass it on to the investigation team.

I initially invested in this company in April 2011 when they announced they would be entering the sports nutrition supplement industry (an interest of mine). Creative Edge Nutrition initially reverse merged into a defunct company (ticker LBGE) in 2011 in order to be able to expedite the process of becoming public and bring products to market. The initial CEO of Creative Edge Nutrition (Paul Thomas) announced a product they were going to formulate called Metabolic Xtreme. It was more of a concept and he was slow in moving it forward, and never actually did.

Creative Edge Nutrition subsequently brought in Bill Chaaban to replace him in April 2012 as the new CEO. Shortly after becoming CEO, Bill Chaaban announced milestones and goals over the next couple years in terms of bringing these sports nutrition products to market. He was starting from scratch. However, not only did he bring Metabolic Xtreme to market, but he quickly brought several other products through research and development and to market, including AminoPlex and HyperInfusion. I still use the AminoPlex nutritional products almost daily, and they are great.

Mr. Chaaban also wanted to get a ticker change to reflect the current business that had nothing to do with the old business, so he had it changed from LBGE to FITX. Not only did he get the nutritional side of the company up and running strongly (which is still ongoing), he announced and began development of the medical marijuana subsidiary (CEN-Biotech) in 3/2013. Given the goals announced for the nutritional side, all of which were followed through on over the next couple years, I knew that Mr. Chaaban had integrity and was goal-driven. So, I knew he would work diligently no differently with the CEN-Biotech subsidiary, which he did from the beginning and has continued to do.

Similarly to how he announced goals and plans for the nutritional side of the company, and followed through on every one of them, he also announced goals and plans for the newly formed subsidiary CEN-Biotech. As investors, we again began to see steady progress from the build out of the facility (following full approvals from the Town of Lakeshore, as well as receiving a Ready to Build letter from Health Canada), industry networking, and other tangible progress, everything continued to appear on track. Bill Chaaban recruited an absolutely amazing board of directors (BOD) and medical team consisting of expert physician-scientists with world-renowned recognition in the medical, scientific, research, and financial industries including a prior senior level executive at Fidelity and JPMorgan (see highlighted links below), as well as John Germinario, who works with the US SEC (securities exchange commission). The magnitude and achievements of this personnel would not be joining just any company if the company was not legitimate.

Everything continued to be on track and correlated accurately with every announcement made. Then, we began to run into delays which were due to Health Canada taking much longer than expected for coming to inspect our facility. These delays were months and months despite the company being ready for inspection. When they finally did come to inspect many months later, the report stated that approval was recommended pending the correction of 2 minor issues (a screen over a vent, and the security camera angle). Again, we began to wait many more months for final approval, even though these minor issues were quickly fixed.

In these months of delay, the Town of Lakeshore began to change their stance. They initially welcomed the company to Lakeshore in a public video http://vimeo.com/83685127

and had received approvals for their facility build-out. However, in more recent months while the delays due to Health Canada were occurring, they also decided to try to change the local bylaws and change the zoning in a way which would inhibit CEN-Biotech from operating. A few nearby residents began to complain about the project with outlandish claims/concerns just as license was coming, despite watching the buildings go up and saying nothing for all of the preceding months. It later came out in a letter by the company to the town councilors that the few neighbors were attempting to extort significant compensation in monetary value and employment in return for their support of the company/building, which the company did not stand for (and rightfully so).

These few neighbors were able to influence their local councilors to attempt to write a new bylaw stating medical cannabis grow-ops need to be zoned industrial, not agricultural (CEN-Bio is agricultural). The mayor also began to flip-flop regarding CEN-Bio, suspected to be politically driven. There have been identical zoning motions passed by other towns that were struck down by the provincial government, saying that grow-ops do not require industrial zoning. The town clearly knew what was being built the whole time, provided building permits, along with the ready to build letter from Health Canada. There was a letter written from these few residents and their attorney to Health Canada as well asking them to delay/avoid license to CEN-Biotech, which added more delay.

Along with the delay from the above issues, we began to see an assault against CEN-Biotech by the media. In particular, Grant Robertson of the Globe and Mail has targeted CEN-Biotech with continuous assault of articles, many of which have not been based on true facts, and twisting of the actual facts. I have watched his articles timed with every time that the stock has a continued uptrend. He will release several articles in a row which causes the stock to drop significantly. I have watched this occur over and over. I honestly feel that he has an agenda against the company, whether it is being funded by trader groups, or competition, or something else. I sincerely hope that he is investigated in this as well, because he is a central piece. Matt Finston and Chris Parry are two bloggers who have also been relentlessly attacking CEN-Biotech during all of the delays they have suffered, driving share price further down. In fact, Grant Roberston has quoted and discussed Matt Finston several times in his articles, and I wouldn't be surprised if these individuals were all working together somehow. I truly hope this investigation is fair and they are all investigated. Matt Finston has also talked about shorting FITX on his Twitter and there are shareholders who have all of these screenshots saved.

There is documentation of Libby Davies meeting with the Tilray lobbyists, and later on Libby was quoted in one of Grant Robertson's bash articles on CEN-Biotech, also attacking the company. I hope that paper and money trails are evaluated with these individuals. The prior CEO of Tweed was also bashing FITX on his Twitter. I feel there is an orchestrated attach against the company, likely from competitors who feel threatened by CEN-Biotech since they would be the largest grower upon licensure, and possibly from trading groups who could be shorting the stock. This is just speculation, but I wouldn't at all be surprised as I have watched everything closely unfold since the beginning. These misleading articles, blogs, and events have influenced Health Canada negatively, which led to license denial for CEN-Biotech.

Please read through this page on the CEN-Biotech website, which addresses many of these issues and investor concerns:
http://www.cenbiotechinc.com/PlatformApps/CEN/c1/faq.html


Never once did I feel misled in anyway by any announcements or public releases. There are over 2100 investors on a dedicated CEN-Biotech investor page on the internet alone who feel the same way, which is why we have stuck it out continuously. We have lost significant value in our investments. This is not because of Bill Chaaban, any statements he has made, or any announcements by the company. These losses are purely due to the events, agendas, and manipulation discussed above, which have erroneously influenced Health Canada. CEN-Biotech has been painted in a very unfair light in the media. As one of many investors, I'm sick of watching it happen with no repercussions against these individuals (such as Grant Robertson, Mayor Tom Bain and councillors, local neighbors in Lakeshore, Matt Finston, and Chris Parry). The only investigation that should be ongoing in my opinion is against Grant Robertson, these aforementioned individuals, the Town of Lakeshore, and Health Canada, rather than the company itself. I sincerely hope that your team will quickly find this to be the case.

For those with disabling neurologic diseases (I changed this line slightly for privacy reasons), it is an absolute shame how much of a delay the company has sustained in beginning their research and development of medical cannabis strains and medications, all due to the influence from misleading articles and manipulative behaviors above, as well as unjust retroactive changes in bylaws that the town of Lakeshore has been attempting to pass. I continued to stay invested in CEN-Biotech because I was excited (and still am) with their plans for moving the science of medical cannabis forward, along with the outstanding medical professionals they had collected on their Board of Directors who would be involved in the research and company. It is honestly quite sad for the patients who need better quality medications, which CEN-Biotech has been waiting to begin production of, only to continue being delayed for unjust reasons as discussed above.

I implore you to please investigate fairly, and please investigate the entities mentioned above who have played the biggest role in loss of shareholder value. I have watched this company unfold from the beginning. I have watched Bill Chaaban attain the company's stated goals until the above issues halted the company's progress. I only hope that these issues will be brought to light and the company is cleared and able to continue with their previously stated goals for the future.

Sincerely,
XXX






.



Unlike · Comment
.






You and 53 others like this.
.








View previous comments
..










Michael Peterman Is there a cliff notes version lol.

Yesterday at 12:51pm · Like · 1

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 4

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Exciting Charity Golf Tournament for Community Support

Updated Category News Views 71

Service Above Self Charity Golf Tournament Returns The Rotary Club of Southern Frederick County is thrilled to announce the return of the annual Service Above Self Charity Golf Tournament. This much-anticipated event will take place at the picturesque Worthington Manor Golf Club and aims to raise funds for vital Rotary programs that serve both local and global...

Continue Reading
Spirit AeroSystems Completes Agreement with Tex Tech Industries

Updated Category News Views 281

Spirit AeroSystems to Sell Fiber Materials, Inc. Spirit AeroSystems Holdings, Inc. (NYSE: SPR) has entered into a purchase agreement to sell the Fiber Materials, Inc. (FMI) business to Tex-Tech Industries, Inc. The transaction involves a cash consideration of $165 million, with customary adjustments. This strategic move reinforces Spirit's commitment to focus on its core...

Continue Reading
Transform Your Investment: The Growth of AECOM Over Five Years

Updated Category News Views 357

Transform Your Investment: The Growth of AECOM Over Five Years AECOM (ACM) has shown impressive market performance over the past five years, achieving an annualized return that exceeds market averages by a notable margin. Currently valued at around $14.27 billion, the company's success reflects its ability to adapt and thrive in a competitive environment. Investment...

Continue Reading
The Quantum Revolution: Transforming Technology and Investments

Updated Category News Views 404

Understanding Quantum Computing and Its Impact Quantum computing stands at the forefront of technological advancement, much like how artificial intelligence (AI) redefined various sectors. This groundbreaking technology is set to usher in a new era, with potential applications that touch multiple industries including cryptography, pharmaceuticals, and optimization...

Continue Reading
CEO Coaching International and Addicus Team Up for Wealth Growth

Updated Category News Views 109

CEO Coaching International and Addicus Forge Strategic Alliance In a significant move to enhance wealth management services for entrepreneurial families, CEO Coaching International proudly announces their collaboration with Addicus as a Diamond Strategic Partner. This partnership aims to combine efforts in helping entrepreneurs safeguard and grow their wealth while...

Continue Reading